Early tumor response evaluation by MRI volumetry

OTHER2 trials

Sponsors

Institut du Cancer de Montpellier - Val d'Aurelle

Conditions

Locally Advanced Malignant NeoplasmRectal Carcinoma

Phase 2

Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma

CompletedNCT01333709

Institut du Cancer de Montpellier - Val d'AurelleLocally Advanced Malignant Neoplasm, Rectal Carcinoma

Start: 2011-05-31End: 2014-09-30Updated: 2017-08-21

Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma

RecruitingNCT04749108

Institut du Cancer de Montpellier - Val d'AurelleLocally Advanced Malignant Neoplasm, Rectal Carcinoma

Start: 2021-11-26End: 2031-09-01Target: 1075Updated: 2026-09-02

Related Papers

Re-evaluating the role of pelvic radiation in the age of modern precision medicine and systemic therapy.

2024-01-01

Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR 4): Long-term Results From a Multicenter, Randomized, Open-Label, Phase II Trial

Diseases of the Colon & Rectum2021-11-1115 citations

Radiomics modelling in rectal cancer to predict disease-free survival: evaluation of different approaches

British journal of surgery2021-05-1046 citations

Tailored treatment strategy for locally advanced rectal carcinoma: Five-year results of the French phase II, randomized, multicenter GRECCAR4 trial.

Journal of Clinical Oncology2020-05-206 citations

Early MRI predictors of disease-free survival in locally advanced rectal cancer from the GRECCAR 4 trial

British journal of surgery2019-08-2223 citations

Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy: Preliminary Results of the French Phase II Multicenter GRECCAR4 Trial.

2017-07-0155 citations